Insider · SEC Forms 3, 4, 5
CIK 1494730
All transactions
Every Form 4 row this person reported, newest first
Insider · SEC Forms 3, 4, 5
Every Form 4 row this person reported, newest first
Readnour Robin Shane (CIK 1914883) reported 8 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-11). Recent activity: Sell ANTX (585 shares), Sell ANTX (523 shares), Sell ANTX (3,223 shares), Sell ANTX (2,877 shares), Sell ANTX (4,725 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-11 | AN2 Therapeutics, Inc. (ANTX) | Director | Sell | 585 | $3,524 |
| 2026-09-11 | AN2 Therapeutics, Inc. (ANTX) | Director | Sell | 523 | $3,151 |
| 2026-09-08 | AN2 Therapeutics, Inc. (ANTX) | Director | Sell | 3,223 | $19,563 |
| 2026-09-08 | AN2 Therapeutics, Inc. (ANTX) | Director | Sell | 2,877 | $17,463 |
| 2026-09-08 | AN2 Therapeutics, Inc. (ANTX) | Director | Sell | 4,725 | $28,436 |
| 2026-09-08 | AN2 Therapeutics, Inc. (ANTX) | Director | Sell | 5,294 | $31,861 |
| 2026-08-19 | AN2 Therapeutics, Inc. (ANTX) | Director | Sell | 16,696 | $100,313 |
| 2026-08-19 | AN2 Therapeutics, Inc. (ANTX) | Director | Sell | 18,706 | $112,389 |
Source: SEC Form 4 filings · as of 2026-09-11